{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:58:09Z","timestamp":1762459089804,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2007]]},"DOI":"10.4158\/ep.13.5.458","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:55:24Z","timestamp":1365198924000},"page":"458-462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical and Bone Density Outcomes of Tumor-Induced Osteomalacia after Treatment"],"prefix":"10.1016","volume":"13","author":[{"given":"Lisa G.","family":"Umphrey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Peter","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtiss B.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.13.5.458_bb0005","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMe030037","article-title":"Oncogenic osteomalacia--a complex dance of factors","volume":"348","author":"Carpenter","year":"2003","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.13.5.458_bb0010","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","article-title":"Tumor-induced osteomalacia","volume":"294","author":"Jan de Beur","year":"2005","journal-title":"JAMA"},{"key":"10.4158\/EP.13.5.458_bb0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4158\/EP.11.2.108","article-title":"Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes","volume":"11","author":"Zimering","year":"2005","journal-title":"Endocr Pract"},{"key":"10.4158\/EP.13.5.458_bb0020","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1359\/jbmr.1997.12.9.1502","article-title":"Tumor-induced osteomalacia: clinical and basic studies","volume":"12","author":"Shane","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP.13.5.458_bb0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/01.wnl.0000225057.56863.33","article-title":"Oncogenic osteomalacia: muscular weakness and multiple fractures","volume":"67","author":"Ladha","year":"2006","journal-title":"Neurology"},{"key":"10.4158\/EP.13.5.458_bb0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2005.01.001","article-title":"Oncogenic osteomalacia: diagnostic implications of fibroblast growth factor 23 and F-18 fuorordeoxyglucose PET\/CT scan for the diagnosis and follow-up in one case","volume":"36","author":"Dupond","year":"2005","journal-title":"Bone"},{"key":"10.4158\/EP.13.5.458_bb0035","doi-asserted-by":"crossref","first-page":"F1170","DOI":"10.1152\/ajprenal.00072.2005","article-title":"\u201cPhosphatonins\u201d and the regulation of phosphorus homeostasis","volume":"289","author":"Berndt","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.4158\/EP.13.5.458_bb0040","first-page":"3459","article-title":"A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets","volume":"83","author":"Econs","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.13.5.458_bb0045","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/154411130401500503","article-title":"The wrickkened pathways of FGF23, MEPE and PHEX","volume":"15","author":"Rowe","year":"2004","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.4158\/EP.13.5.458_bb0050","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","article-title":"Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia","volume":"91","author":"Imel","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.13.5.458_bb0055","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-021919","article-title":"Clinical case seminar: fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia","volume":"88","author":"Nelson","year":"2003","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20420385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20420385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/R8524T2145372318.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:47:31Z","timestamp":1761515251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20420385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"alternative-id":["S1530891X20420385"],"URL":"https:\/\/doi.org\/10.4158\/ep.13.5.458","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2007]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Bone Density Outcomes of Tumor-Induced Osteomalacia after Treatment","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.13.5.458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}